HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

[A novel neurocutaneous syndrome: Legius syndrome. A case report].

AbstractINTRODUCTION:
Legius syndrome is an autosomal dominant disorder caused by the mutation in the SPRED1 gene involving a negative regulator of the RAS-MAPK pathway, similar to neurofibromin and therefore shows some clinical similarities to neurofibromatosis type I (NF1) but less severe. These patients have multiple cafe-au-lait spots, sometimes associated with skin fold freckling, dysmorphic features, lipomas, and mild learning disabilities. However, this syndrome is not associated with neurofibromas, optic gliomas, Lisch nodules or tumor predisposition.
CASE REPORT:
We present a 10 months child, without a personal interest history, consulting by hypotonic extremities, cafe-au-lait spots and mild psychomotor difficult. Mother's sister and grandfather have some cafe-au-lait spots. In our patient, NF1 genetic study was negative, but we observe a mutation in the SPRED1 gene, compatible with Legius syndrome. Asymptomatic mother shows the same mutation in SPRED1 gene.
CONCLUSION:
We emphasize the relevance of the differential diagnosis of NF1 with respect to numerous complications to appear, with a better prognosis recently described entity as it is Legius syndrome.
AuthorsMercedes Cemeli-Cano, José Luis Peña-Segura, Ruth Fernando-Martínez, Silvia Izquierdo-Álvarez, Lorena Monge-Galindo, Javier López-Pisón
JournalRevista de neurologia (Rev Neurol) Vol. 59 Issue 5 Pg. 209-12 (Sep 01 2014) ISSN: 1576-6578 [Electronic] Spain
Vernacular TitleUn nuevo síndrome neurocutáneo: síndrome de Legius. A propósito de un caso.
PMID25156025 (Publication Type: Case Reports, English Abstract, Journal Article)
Topics
  • Cafe-au-Lait Spots (diagnosis)
  • Humans
  • Infant
  • Male

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: